VIRTUSA back into organisations and providing new avenues of revenue opportunities while simultaneously expanding quality outcomes and deliverables .
Stoudt provided details around the first two combined products for Virtusa which will be Revenue Recovery and Contract Management .
Revenue Recovery is focused on Retrospective Medical Necessity Denials / Appeals and recovering revenue that is owed to hospital organisations . Stoudt discusses how millions of dollars are written off each year by CFO ’ s when unable to provide updated or correct clinical information back to payers . Stoudt discussed how critical it is for provider organisations who are writing off millions of dollars in the market today as
Superior Technology with Clinical Expertise . Stoudt noted that this delivery model is unparalleled in the market today as the majority of companies focus either on the technology or separately the clinical components . Virtusa will bring the combined solution to the provider market which will enhance and grow hospital organisations revenue but also provides the clinical expertise to provide improved healthcare outcomes and operational efficiencies .
Stoudt has worked in senior and executive positions in both Provider and Payer organisations . Her expertise in building successful business units for some of the industry ’ s leading organisations has driven strong financial / operational results . After building numerous companies within companies , she developed and brought to market-Revenue Clinical Solutions ( RCS ). RCS delivers clinical products and services to both the provider and payer markets that focus on driving revenue
“ We are a medium-sized company , and we tend to be very collaborative in how we work . So when we partner with a client , we want to fit into not only their ecosystem of employees and partners but very deeply embed ourselves in their culture as well . We spend a lot of time trying to adapt to that different type of culture ”
ANTHONY LANGE SENIOR VICE PRESIDENT & HEAD OF HEALTHCARE AND LIFE SCIENCES , VIRTUSA
136 August 2021